Stock Markets July 30, 2026 05:20 AM

Pirelli Shares Drop After H1 Results and JPMorgan Downgrade

Slowing organic growth, rising cost headwinds and board dissent combine to pressure the tiremaker's stock

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
SPMI

Pirelli shares declined following the release of the company's H1 2026 results and an immediate downgrade by JPMorgan. Investors reacted to a slowdown in second-quarter organic growth, inflation and FX headwinds in the first half, and a revised, weaker raw material cost outlook for the full year. Additional selling pressure came amid a soft Italian equity session and signs of shareholder friction at the board level.

Pirelli Shares Drop After H1 Results and JPMorgan Downgrade
SPMI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Pirelli reported H1 net sales of 03,495 million; Q2 organic growth decelerated to 1.4% excluding FX and hyperinflation.
  • The company upheld full-year revenue guidance of 06.7506.95 billion and an adjusted EBIT margin of roughly 16%, but flagged a worsened raw material cost outlook amounting to a 070 million headwind.
  • JPMorgan downgraded Pirelli from Overweight to Neutral with a 07.20 price target; board approval of H1 results featured dissent from three Chinese-affiliated directors over a control declaration by MTP Spa.

Summary: Pirelli stock moved lower after the company posted its H1 2026 figures and JPMorgan changed its recommendation. Market participants seized on slower organic expansion in the second quarter, material cost pressures and foreign exchange and inflation impacts reported for the first half. The reaction was compounded by a governance dispute noted at the board meeting and a broadly muted backdrop on Piazza Affari.

Pirelli shares fell 2.3% to trade at 06.355 after the H1 2026 results were published after the market close on July 29 and a same-day downgrade from JPMorgan triggered additional selling during the trading session. The stock reached an intraday low of 06.235, below the previous close of 06.505.

The tiremaker recorded net sales of 03,495 million for the first half, effectively flat on a reported basis. Organic growth in the second quarter slowed to 1.4% when excluding foreign exchange movements and hyperinflation effects. Management reiterated its full-year revenue guidance of 06.7506.95 billion and maintained an adjusted EBIT margin target of roughly 16% for the year.

Despite the unchanged top-line guidance, investors homed in on several downside elements disclosed in the H1 report. The company cited 044 million of adverse FX effects and 065 million in inflation-related costs during the first half. Crucially, Pirelli revised its raw material cost outlook, flagging a 070 million headwind for the full year - a deterioration versus prior expectations.

The most immediate market catalyst was JPMorgan's move to lower its stance on the stock from Overweight to Neutral, with a price target set at 07.20. Analysts at the bank cited the slowdown in organic growth and the tougher cost environment following the Q2 disclosure as reasons for stepping back from a bullish recommendation.

Corporate governance dynamics added another element to the selloff. Pirelli's board approved the H1 results, but three directors with Chinese affiliations - Zhang Haitao, Xi Xiaohong and Wang Kun - registered dissenting votes. Their objection related to a declaration of control by MTP Spa included in the financial report, an issue that has surfaced previously between the Italian and Chinese shareholder groups.

On the wider market, Milan's FTSE MIB index was under pressure mid-session amid earnings-driven selling across a number of names. Saipem in particular posted a sharp decline after reporting quarterly results that fell short of expectations and trimming its 2026 EBITDA guidance. The mixed trading day on Piazza Affari - where some defence stocks helped limit losses elsewhere - did not provide a meaningful tailwind for Pirelli.

High-value tire peers in the European auto-parts sector, including Continental and Brembo, also faced headwinds during the session. Meanwhile, U.S. equity markets were modestly positive and offered little macro relief for the Italian-listed tyre group.

Taken together, the combination of a post-earnings analyst downgrade, decelerating top-line momentum, a more challenging raw material cost outlook and a soft Italian equity backdrop produced a confluence of selling pressure. The stock traded materially below its 52-week high of 07.165, while remaining above its 52-week low of 05.31.


Key takeaways

  • Pirelli posted H1 net sales of 03,495 million and second-quarter organic growth slowed to 1.4% excluding FX and hyperinflation.
  • Management kept full-year revenue guidance at 06.7506.95 billion and an adjusted EBIT margin near 16%, but flagged a deteriorated raw material cost outlook of a 070 million headwind for the year.
  • JPMorgan downgraded Pirelli from Overweight to Neutral with a 07.20 price target, and three Chinese-affiliated board members dissented on the H1 approval over a control declaration by MTP Spa.

Market context

Weakness in Milan's equity market, earnings-driven declines at other corporates and pressure across high-end tire and auto-parts names contributed to the session's unfavorable conditions for Pirelli.

Risks

  • Higher raw material costs - the revised outlook points to a 070 million headwind for the full year, which may press margins - this primarily affects industrials and materials-intensive sectors such as auto-parts and tire manufacturing.
  • Currency and inflation pressures - H1 included 044 million of FX headwinds and 065 million of inflation costs, risks that impact revenue and cost dynamics across multinational exporters.
  • Shareholder and governance friction - dissenting votes by Chinese-affiliated directors on the board raise uncertainty around shareholder relations and corporate control matters, which could influence investor sentiment in the near term.

More from Stock Markets

Las Vegas Sands Shares Slip After Argus Downgrade, Adding to Post-Earnings Pressure Jul 30, 2026 Align Technology Shares Drop After Revenue Guide Miss, Scanner Business Slump and One-Time Tax Charge Jul 30, 2026 ImmunityBio Shares Rise After UAE Clears ANKTIVA for Two Cancer Indications Jul 30, 2026 EU to Back Seven AI 'Gigafactories' with €10 Billion, Seeks Private Capital to Narrow Tech Gap Jul 30, 2026 HII Rally Accelerates After Q2 Beat and Massive Navy Contract Award Jul 30, 2026